{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:50:54Z","timestamp":1790398254640,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026962"],"award-info":[{"award-number":["R01EY026962"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["G2023009S"],"award-info":[{"award-number":["G2023009S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81659-6","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T02:27:20Z","timestamp":1735352840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor"],"prefix":"10.1038","volume":"14","author":[{"given":"Jiannong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga Pradeep","family":"Rayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenna Kesavulu","family":"Sugali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon H.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamesh","family":"Dhamodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Dalloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"81659_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/039463201202500307","volume":"25","author":"E Bianchi","year":"2012","unstructured":"Bianchi, E. et al. Immunohistochemical profile of VEGF, TGF-beta and PGE(2) in human pterygium and normal conjunctiva: experimental study and review of the literature. Int. J. Immunopathol. Pharmacol. 25, 607\u2013615. https:\/\/doi.org\/10.1177\/039463201202500307 (2012).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"81659_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00417-003-0846-y","volume":"242","author":"W Naib-Majani","year":"2004","unstructured":"Naib-Majani, W. et al. Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefes Arch. Clin. Exp. Ophthalmol. 242, 332\u2013338. https:\/\/doi.org\/10.1007\/s00417-003-0846-y (2004).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"81659_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ajpath.2010.10.037","volume":"178","author":"J Chui","year":"2011","unstructured":"Chui, J. et al. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am. J. Pathol. 178, 817\u2013827. https:\/\/doi.org\/10.1016\/j.ajpath.2010.10.037 (2011).","journal-title":"Am. J. Pathol."},{"key":"81659_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.scr.2015.10.008","volume":"15","author":"M Notara","year":"2015","unstructured":"Notara, M. et al. Short-term uvb-irradiation leads to putative limbal stem cell damage and niche cell-mediated upregulation of macrophage recruiting cytokines. Stem Cell. Res. 15, 643\u2013654. https:\/\/doi.org\/10.1016\/j.scr.2015.10.008 (2015).","journal-title":"Stem Cell. Res."},{"key":"81659_CR5","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2147\/OPTH.S186543","volume":"12","author":"R Nuzzi","year":"2018","unstructured":"Nuzzi, R. & Tridico, F. How to minimize pterygium recurrence rates: clinical perspectives. Clin. Ophthalmol. 12, 2347\u20132362. https:\/\/doi.org\/10.2147\/OPTH.S186543 (2018).","journal-title":"Clin. Ophthalmol."},{"key":"81659_CR6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archopht.1989.01070020555039","volume":"107","author":"HR Taylor","year":"1989","unstructured":"Taylor, H. R. et al. Corneal changes associated with chronic UV irradiation. Arch. Ophthalmol. 107, 1481\u20131484. https:\/\/doi.org\/10.1001\/archopht.1989.01070020555039 (1989).","journal-title":"Arch. Ophthalmol."},{"key":"81659_CR7","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1016\/S0021-9258(18)53311-1","volume":"268","author":"M Kramer","year":"1993","unstructured":"Kramer, M., Sachsenmaier, C., Herrlich, P. & Rahmsdorf, H. J. UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response. J. Biol. Chem. 268, 6734\u20136741 (1993).","journal-title":"J. Biol. Chem."},{"key":"81659_CR8","first-page":"S5","volume":"30","author":"SK Singh","year":"2017","unstructured":"Singh, S. K. Pterygium: epidemiology prevention and treatment. Community Eye Health. 30, S5\u2013S6 (2017).","journal-title":"Community Eye Health"},{"key":"81659_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/bjo.2008.152694","volume":"93","author":"S West","year":"2009","unstructured":"West, S. & Munoz, B. Prevalence of pterygium in latinos: Proyecto VER. Br. J. Ophthalmol. 93, 1287\u20131290. https:\/\/doi.org\/10.1136\/bjo.2008.152694 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"81659_CR10","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1167\/iovs.07-0878","volume":"48","author":"M Honjo","year":"2007","unstructured":"Honjo, M. et al. Potential role of rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 48, 5549\u20135557. https:\/\/doi.org\/10.1167\/iovs.07-0878 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"81659_CR11","doi-asserted-by":"publisher","unstructured":"Igarashi, N. et al. Activation of the sphingosine 1 phosphate-rho pathway in Pterygium and in Ultraviolet-irradiated normal conjunctiva. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20194670 (2019).","DOI":"10.3390\/ijms20194670"},{"key":"81659_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/02713683.2021.1962363","volume":"47","author":"J Xie","year":"2022","unstructured":"Xie, J., Ning, Q., Zhang, H., Ni, S. & Ye, J. RhoA\/ROCK signaling regulates TGF-beta1-Induced Fibrotic effects in human pterygium fibroblasts through MRTF-A. Curr. Eye Res. 47, 196\u2013205. https:\/\/doi.org\/10.1080\/02713683.2021.1962363 (2022).","journal-title":"Curr. Eye Res."},{"key":"81659_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.clae.2017.04.002","volume":"40","author":"N Josifovska","year":"2017","unstructured":"Josifovska, N. et al. Cultivation and characterization of pterygium as an ex vivo study model for disease and therapy. Cont. Lens Anterior Eye. 40, 283\u2013292. https:\/\/doi.org\/10.1016\/j.clae.2017.04.002 (2017).","journal-title":"Cont. Lens Anterior Eye"},{"key":"81659_CR14","doi-asserted-by":"publisher","unstructured":"Palewski, M., Budnik, A. & Konopinska, J. Evaluating the efficacy and safety of different Pterygium surgeries: a review of the literature. Int. J. Environ. Res. Public. Health. 19 https:\/\/doi.org\/10.3390\/ijerph191811357 (2022).","DOI":"10.3390\/ijerph191811357"},{"key":"81659_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/ced.12067","volume":"38","author":"VD Gandham","year":"2013","unstructured":"Gandham, V. D. et al. Effects of Y27632 on keratinocyte procurement and wound healing. Clin. Exp. Dermatol. 38, 782\u2013786. https:\/\/doi.org\/10.1111\/ced.12067 (2013).","journal-title":"Clin. Exp. Dermatol."},{"issue":"Suppl 11","key":"81659_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/ICO.0000000000000240","volume":"33","author":"N Koizumi","year":"2014","unstructured":"Koizumi, N., Okumura, N., Ueno, M. & Kinoshita, S. New therapeutic modality for corneal endothelial disease using rho-associated kinase inhibitor eye drops. Cornea 33 (Suppl 11), 25\u201331. https:\/\/doi.org\/10.1097\/ICO.0000000000000240 (2014).","journal-title":"Cornea"},{"key":"81659_CR17","doi-asserted-by":"publisher","first-page":"105463","DOI":"10.1016\/j.phrs.2021.105463","volume":"165","author":"R Roskoski","year":"2021","unstructured":"Roskoski, R. Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update. Pharmacol. Res. 165, 105463. https:\/\/doi.org\/10.1016\/j.phrs.2021.105463 (2021).","journal-title":"Pharmacol. Res."},{"key":"81659_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41433-019-0671-0","volume":"34","author":"NA Mehran","year":"2020","unstructured":"Mehran, N. A., Sinha, S. & Razeghinejad, R. New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost. Eye (Lond). 34, 72\u201388. https:\/\/doi.org\/10.1038\/s41433-019-0671-0 (2020).","journal-title":"Eye (Lond)"},{"key":"81659_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","volume":"125","author":"AP Tanna","year":"2018","unstructured":"Tanna, A. P. & Johnson, M. Rho kinase inhibitors as a Novel treatment for Glaucoma and ocular hypertension. Ophthalmology 125, 1741\u20131756. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.040 (2018).","journal-title":"Ophthalmology"},{"key":"81659_CR20","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.conctc.2023.101160","volume":"33","author":"Y Mizuno","year":"2023","unstructured":"Mizuno, Y. et al. A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy. Contemp. Clin. Trials Commun. 33, 101160. https:\/\/doi.org\/10.1016\/j.conctc.2023.101160 (2023).","journal-title":"Contemp. Clin. Trials Commun."},{"key":"81659_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cbf.3382","volume":"37","author":"DG Ibrahim","year":"2019","unstructured":"Ibrahim, D. G., Ko, J. A., Iwata, W., Okumichi, H. & Kiuchi, Y. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a rho kinase inhibitor. Cell. Biochem. Funct. 37, 113\u2013124. https:\/\/doi.org\/10.1002\/cbf.3382 (2019).","journal-title":"Cell. Biochem. Funct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81659-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:03:56Z","timestamp":1735401836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81659-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81659-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30930"}}